Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

486 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Acute effect of orlistat on post-prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus.
Tan KC, Tso AW, Tam SC, Pang RW, Lam KS. Tan KC, et al. Diabet Med. 2002 Nov;19(11):944-8. doi: 10.1046/j.1464-5491.2002.00823.x. Diabet Med. 2002. PMID: 12421432 Clinical Trial.
Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus.
Tan KC, Chow WS, Tam SC, Ai VH, Lam CH, Lam KS. Tan KC, et al. J Clin Endocrinol Metab. 2002 Feb;87(2):563-8. doi: 10.1210/jcem.87.2.8249. J Clin Endocrinol Metab. 2002. PMID: 11836286 Clinical Trial.
Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria.
Tan KC, Chow WS, Ai VH, Lam KS. Tan KC, et al. Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):71-6. doi: 10.1002/dmrr.255. Diabetes Metab Res Rev. 2002. PMID: 11921421 Clinical Trial.
Hyperhomocysteinemia and impaired vasomotor function in type 2 diabetes mellitus.
Tan KC, O K, Chow WS, Ai VH, Siow YL, Lam KS. Tan KC, et al. Eur J Clin Invest. 2002 May;32(5):328-34. doi: 10.1046/j.1365-2362.2002.00990.x. Eur J Clin Invest. 2002. PMID: 12027872
Advanced glycation end products and endothelial dysfunction in type 2 diabetes.
Tan KC, Chow WS, Ai VH, Metz C, Bucala R, Lam KS. Tan KC, et al. Diabetes Care. 2002 Jun;25(6):1055-9. doi: 10.2337/diacare.25.6.1055. Diabetes Care. 2002. PMID: 12032114
Feline diabetes--personal experience.
Tan KC. Tan KC. Diabet Med. 2003 Jan;20(1):80. doi: 10.1046/j.1464-5491.2003.00817_1.x. Diabet Med. 2003. PMID: 12519326 No abstract available.
Plasma phospholipid transfer protein activity and small, dense LDL in type 2 diabetes mellitus.
Tan KC, Shiu SW, Wong Y. Tan KC, et al. Eur J Clin Invest. 2003 Apr;33(4):301-6. doi: 10.1046/j.1365-2362.2003.01132.x. Eur J Clin Invest. 2003. PMID: 12662160
Effect of the microsomal triglyceride transfer protein -493 G/T polymorphism and type 2 diabetes mellitus on LDL subfractions.
Chen SP, Tan KC, Lam KS. Chen SP, et al. Among authors: tan kc. Atherosclerosis. 2003 Apr;167(2):287-92. doi: 10.1016/s0021-9150(03)00004-2. Atherosclerosis. 2003. PMID: 12818411
C-reactive protein predicts the deterioration of glycemia in chinese subjects with impaired glucose tolerance.
Tan KC, Wat NM, Tam SC, Janus ED, Lam TH, Lam KS. Tan KC, et al. Diabetes Care. 2003 Aug;26(8):2323-8. doi: 10.2337/diacare.26.8.2323. Diabetes Care. 2003. PMID: 12882856
Effects of treatment with Sandostatin LAR on small dense LDL and remnant-like lipoproteins in patients with acromegaly.
Tan KC, Pang RW, Tiu SC, Lam KS. Tan KC, et al. Clin Endocrinol (Oxf). 2003 Nov;59(5):558-64. doi: 10.1046/j.1365-2265.2003.01849.x. Clin Endocrinol (Oxf). 2003. PMID: 14616878 Clinical Trial.
486 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback